Search Results
FDA Approves Biogen’s Tofersen Drug for Rare Form of ALS
Drug for rare form of ALS benefits some patients
BREAKING: FDA Approves Qalsody for ALS
Oral Testimony to the FDA Advisory Committee on the Approval of tofersen
Tofersen (Qalsody), First FDA Approved Medication For SOD1-ALS (Amyotrophic Lateral Sclerosis)
US FDA panel backs accelerated approval for Biogen's ALS drug|#shorts
Tofersen and the FDA Approval Process
Tofersen and the Future of ALS Drug Development
FDA poised to approve a new drug for ALS Part 2 #sharecare #shorts
Pressure Mounting On Pharma Company Biogen To Give New Drug In Trials To N.J. Woman With Rare Form O
Why FDA Decision on Tofersen Matters
The Brewing FDA Battle Over ALS Treatment
